Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Abdulrahman S Alanazi"'
Publikováno v:
Saudi Journal of Medicine and Medical Sciences, Vol 4, Iss 1, Pp 9-14 (2016)
Pharmaceutical care can be given in all settings: The community, hospitals, long-term care, and the clinic. However, published literature indicates that there is a substantial barrier to implementing pharmaceutical care programs in community pharmaci
Externí odkaz:
https://doaj.org/article/722140ca74c04aab96f2b80403119d7c
Autor:
Wael A. Alanazi, Hussain N. Alhamami, Metab Alharbi, Khalid Alhazzani, Abdulrahman S. Alanazi, Sary Alsanea, Nemat Ali, Abdullah F. Alasmari, Ahmed Z. Alanazi, Moureq R. Alotaibi, Mohammed Alswayyed
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 8, Pp 1159-1169 (2022)
Gefitinib is a tyrosine kinase inhibitor (TKI) of the epidermal growth factor receptor (EGFR), used for the treatment of advanced or metastatic non-small cell lung cancer. Recently, studies proved that Gefitinib-induced cardiotoxicity through inducti
Externí odkaz:
https://doaj.org/article/ffd8774970444e2db83a36fd880b8ec0
Autor:
Wael A. Alanazi, Abdulrahman S. Alanazi, Doaa M. El-Nagar, Abdullah M. Aljuraybah, Sary Alsanea, Metab Alharbi
Publikováno v:
Pharmaceuticals, Vol 16, Iss 2, p 295 (2023)
Tivozanib is a triple vascular endothelial growth factor receptor inhibitor, recently approved for the treatment of refractory advanced renal cell carcinoma. Clinical studies showed that around 46% of patients who received tivozanib suffer from hyper
Externí odkaz:
https://doaj.org/article/72f2a0d0d629430c97dc3402f82597f8
Autor:
Mohammed A. Alshawsh, Sanaz Koosha, Faizul Azam, Abdulrahman S Alanazi, Habibullah Khalilullah, Eltayeb E M Eid, Ismail M. Taban, Mothanna Sadiq Al-Qubaisi, Alian A. Alrasheedy
Publikováno v:
Molecules
Volume 24
Issue 14
Molecules, Vol 24, Iss 14, p 2554 (2019)
Volume 24
Issue 14
Molecules, Vol 24, Iss 14, p 2554 (2019)
Cell-penetrating peptides (CPPs) are highly promising tools to deliver therapeutic molecules into tumours. &alpha
V&beta
3 integrins are cell&ndash
matrix adhesion receptors, and are considered as an attractive target for anticancer th
V&beta
3 integrins are cell&ndash
matrix adhesion receptors, and are considered as an attractive target for anticancer th
Publikováno v:
Saudi Journal of Medicine & Medical Sciences
Saudi Journal of Medicine and Medical Sciences, Vol 4, Iss 1, Pp 9-14 (2016)
Saudi Journal of Medicine and Medical Sciences, Vol 4, Iss 1, Pp 9-14 (2016)
Pharmaceutical care can be given in all settings: The community, hospitals, long-term care, and the clinic. However, published literature indicates that there is a substantial barrier to implementing pharmaceutical care programs in community pharmaci
Autor:
Abdulrahman S Alanazi
Publikováno v:
Saudi Pharmaceutical Journal. 23:603-613
Combinational therapies are often required in the management of type 2 diabetes mellitus (T2DM). Among the important candidates, dipeptidyl peptidase-4 inhibitors (DPPIs) and metformin combination (DPPI-MET) have shown promising endeavors. In order t
Publikováno v:
Journal of Applied Pharmacy.
The present study aims to evaluate the antidiabetic effect of Morus alba L. stem bark extract in experimental model of diabetes. The animals were divided into six groups as: control group (I); pathogenic control group (II) injected intravenously (i.v
Autor:
Abdulrahman S. Alanazi
Publikováno v:
Saudi Pharmaceutical Journal. 21(3):233-243
Autism and related disorders are increasingly prevalent behavioral syndromes of impaired verbal and nonverbal communication and socialization owing to neurodevelopmental abnormalities. The most recent estimate for the prevalence of autistic disorders
Autor:
Eltayeb E. M. Eid, Abdulrahman S. Alanazi, Sanaz Koosha, Alian A. Alrasheedy, Faizul Azam, Ismail M. Taban, Habibullah Khalilullah, Mothanna Sadiq Al-Qubaisi, Mohammed A. Alshawsh
Publikováno v:
Molecules, Vol 24, Iss 14, p 2554 (2019)
Cell-penetrating peptides (CPPs) are highly promising tools to deliver therapeutic molecules into tumours. αVβ3 integrins are cell−matrix adhesion receptors, and are considered as an attractive target for anticancer therapies owing to their roles
Externí odkaz:
https://doaj.org/article/2e0f5b06dae645c7af90c79513c655a3